The distal half of chromosome 1p was analysed with 15 polymorphic microsatellite markers in 683 human solid tumours at different locations. Loss of heterozygosity (LOH) was observed at least at one site in 369 cases or 54% of the tumours. LOHs detected ranged from 30–64%, depending on tumour location. The major results regarding LOH at different tumour locations were as follows: stomach, 20/38 (53%); colon and rectum, 60/109 (55%); lung, 38/63 (60%); breast, 145/238 (61%); endometrium, 18/25 (72%); ovary, 17/31 (55%); testis, 11/30 (37%); kidney, 22/73 (30%); thyroid, 4/14 (29%); and sarcomas, 9/14 (64%). High percentages of LOH were seen in the 1p36.3, 1p36.1, 1p35–p34.3, 1p32 and 1p31 regions, suggesting the presence of tumour-suppressor genes. All these regions on chromosome 1p show high LOH in more than one tumour type. However, distinct patterns of LOH were detected at different tumour locations. There was a significant separation of survival curves, with and without LOH at chromosome 1p, in the breast cancer patients. Multivariate analysis showed that LOH at 1p in breast tumours is a better indicator for prognosis than the other variables tested in our model, including nodal metastasis.
Arlt, M. F., Herzog, T. J., Mutch, D. G., Gersell, D. J., Liu, H. & Goodfellow, P. J. (1996). Frequent deletions of chromosome 1p sequences of aggressive histologic subtype of endometrial cancer. Hum Mol Genet 5: 1017–1021.
Bardi, G., Pandis, N., Fenger, C., Kronborg, O., Bomme, L. & Heim, S. (1993). Deletion of 1p36 as primary chromosomal aberration in intestinal tumorigenesis. Cancer Res, 53: 1895–1898.
Bello, M. J., de Campos, J. M., Kusak, M. E., Vaquero, J., Sarasa, J. L., Pestana, A. & Rey, J. A. (1994). Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer, 9: 296–298.
Bieche, I., Champème, M. H. & Lidereau, R. (1994). A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res 54: 4274–4276.
Bodmer, J. L., Burns, K., Sneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schroter, M., Becker, K., Wilson, A., French, L. E., Browning, J. L., MacDonald, H. R. & Tschopp, J. (1997). Tramp, a novel apotosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity, 6: 79–88.
Buyse, I. M., Takahashi, E. I. & Huang, S. (1996). Physical mapping of retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics, 15: 119–121.
Caron, H., Peter, M., van Sluis, P., Speleman, F., de Kraker, J., Laureys, G., Michon, J., Brugieres, L., Voute, P. A., Westerveld, A., Slater, R., Delattre, O. & Versteeg, R. (1995). Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet, 4: 535–539.
Caron, H., van Sluis, P., de Kraker, J., Bokkerink, J., Egeler, M., Laureys, G., Slater, R., Westerveld, A., Voute, P. A. & Versteeg, R. (1996). Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med, 334: 225–230.
Cavenee, W. K. & White, R. L. (1995). The genetic basis of cancer. An accumulation of genetic defects can apparently cause normal cells to become cancerous and cancerous cells to become increasingly dangerous. Sci Am (March) 72–79.
Chase, P. B., Yang, J. M., Thompson, F. H., Halonen, M. & Regan, J. W. (1996). Regional mapping of the platelet-activating factor receptor gene (PTAFR) to 1p35–p34.3 by fluorescence in situ hybridisation. Cytogenet Cell Genet 72: 205–207.
Chen, L. C., Kurisu, W., Ljung, B. M., Goldman, E. S., Moore, D. I. I. & Smith, H. S. (1992). Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84: 506–510.
Cox, D. R. (1972). Regression models and life-tables. J R Stat Soc (B) 34: 187–220.
Di Vinci, A., Infusini, E., Peveri, C., Risio, C., Rossini, F. P. & Giaretti, W. (1996). Deletions at chromosome 1p by fluorescence in situ hybridisation are an early event in human colorectal tumorigenesis. Gastroenterology 111: 102–107.
Dracopoli, N. C., Harnett, P., Bale, S. J., Stanger, B. Z., Tucker, M. A., Housman, D. E. & Kefford, R. F. (1989). Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA, 86: 4614–4618.
Duncan, A. M. V., Anderson, L. L., Funk, C. D., Abramovitz, M. & Adam, M. (1995). Chromosomal localisation of the prostanoid receptor gene family. Genomics, 25: 740–742.
Ezaki, T., Yanagisawa, A., Otha, K., Aiso, S., Watanabe, M., Hibi, T., Kato, Y., Nakajima, T., Ariyama, T., Inazawa, J., Nakamura, Y. & Horii, A. (1996). Deletions mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer, 73: 424–428.
Haber, D. & Harlow, E. (1997). Tumor-suppressor genes: evolving definitions in the genomic age. Nat Genet 16: 320–322.
Hey, Y., Hoggard, N., Brintnell, B., James, L., Jones, D., Mitchell, E., Weissenbach, J. & Varley, J. M. (1996). Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Cytogenet Cell Genet, 72: 148
Johnson, D. W., Qumsiyeh, M. & Benkhalifa, M. (1995). Assignment of human transforming growth factor-beta type I and type III receptor genes (TGFRBR1 and TGFBR3) to 9q33-q34 and 1p32–p33, respectively. Genomics, 28: 356–357.
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809–819.
Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
Kemper, O., Derre, J., Cherif, D., Engelmann, H., Wallach, D. & Berger, R. (1991). The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2–p36.3. Hum Genet, 87: 623–624.
Kuroki, T., Fujiwara, Y., Tsuchiya, E., Nakamori, S., Imaoka, S., Kanematsu, T. & Nakamura, Y. (1995). Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosom Cancer, 13: 163–167.
Kwon, B. S., Tan, K. B., Ni, J., Lee, K. O., Kim, K. K., Kim, Y. J., Wang, S., Gentz, R., Yu, G. L., Harrop, J., Lyn, S. D., Silverman, C., Porter, T. G., Truneh, A. & Young, P. R. (1997). A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272: 14272–14276.
Lahti, J. M., Valentine, M., Xiang, J., Jones, B., Amann, J., Grenet, J., Richmond, G., Look, A. T. & Kidd, V. J. (1994). Alteration in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat Genet, 7: 370–375.
Lapointe, J., Lachance, Y. & Labrie, C. (1996). A p18 mutant defective in cdk6 binding in human breast cancer cells. Cancer Res, 56: 4586–4589.
Lees, J. A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N. & Helin, K. (1993). The retinoblastoma protein binds to a family of E2F transcriptional factors. Mol Cell Biol, 13: 7813–7825.
Mantel, N. (1960). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163–170.
Mathew, C. G. P., Smith, B. A., Thorpe, K., Wong, Z., Royle, N. J., Jeffreys, A. J. & Ponder, B. A. J. (1987). Deletion of genes on chromosome 1 in endocrine neoplasia. Nature, 328: 524–526.
Mathew, S., Murty, V. V., Bosl, G. J. & Chaganti, R. S. (1994). Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res, 54: 6265–6269.
Miller, S. A., Dykes, D. D. & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res, 16: 1215
Modi, W. S., Farrar, W. L. & Howard, O. M. Z. (1995). Confirmed assignment of a novel human tyrosine kinase gene (JAK1A) to 1p32.3–31.3 by non isotopic in situ hybridization. Cytogenet Cell Genet, 69: 232–234.
Munn, K. E., Walker, R. A. & Varley, J. M. (1995). Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene, 10: 1653–1657.
Ogunbiyi, O. A., Goodfellow, P. J., Gagliardi, G., Swanson, P. E., Birnbaum, E. H., Fleshman, J. W., Kodner, I. J. & Moley, J. F. (1997). Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology, 113: 761–766.
Ozawa, K., Dean, F. B., Chen, M., Lee, S. H., Shiratori, A., Murakami, Y., Sakura, T., Hurwitz, J. & Eki, T. (1993). Mapping of the 70 kDa, 34 kDa, and a 11 kDa subunit of the human multimeric single-stranded DNA binding protein /hSSB/RPA) to chromosome bands 17p13, 1p35–p36.1, and 7p21–p22. Cell Struct Funct, 18: 221–230.
Praml, C., Savelyeva, L., Le Paslier, D., Siracusa, L. D., Buchberg, A. M., Schwab, M. & Amler, L. C. (1995). Human homologue of a candidate for the MOM1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35–36.1/D1S199. Cancer Res, 55: 5504–5506.
Ragnarsson, G., Sigurdsson, A., Eiriksdottir, G., Barkardottir, R. B., Jonasson, J. G. & Ingvarsson, S. (1996). Loss of heterozygosity at chromosomes 1p in human breast cancer – association with high S-phase, reduced patients survival, and deletions at other chromosome regions. Int J Oncol 9: 731–736.
Rasio, D., Murakumo, Y., Robbins, D., Roth, T., Silver, A., Negrini, M., Schmidt, C., Burczak, J., Fishel, R. & Croce, C. M. (1997). Characterisation of the human homologue of RAD54 — a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors. Cancer Res 57: 2378–2383.
Saito, T., Seki, N., Matsuda, Y., Kitahara, M., Murata, M., Kanda, N., Nomura, N., Yamamoto, T. & Hori, T. A. (1995). Identification of the human ERK gene as a putative receptor tyrosine kinase and its chromosomal localisation to 1p36.1: a comparative mapping of human, mouse, and rat chromosomes. Genomic, 26: 382–384.
Smith, S. A., Easton, D. F., Evans, D. G. & Ponder, B. A. (1992). Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet, 2: 128–131.
Speleman, F., Van Camp, G. & Van Roy, N. (1996). Reassignment of MYCL1 to human chromosome 1p34.3 by fluorescence in situ hybridization. Cytogenet Cell Genet, 72: 189–190.
Steenman, M., Redeker, B., de Meulemeester, M., Wiesmeijer, K., Voute, P. A., Westerveld, A., Slater, R. & Mannens, M. (1997). Comparative genomic hybridization analysis of Wilms tumor. Cytogenet Cell Genet 77: 296–303.
Stock, C., Ambros, I. M., Lion, T., Haas, O. A., Zoubek, A., Gadner, H. & Ambros, P. F. (1994). Detection of numerical and stuctural chromosome abnormalities in paediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes Cancer, 11: 40–50.
Sulman, E. P., Tang, X. X., Allen, C., Biegel, J. A., Pleasure, D. E., Brodeur, G. M. & Ikegaki, N. (1997). ECK, a human EPH-related gene maps to 1p36.1, a common region of alteration in human cancer. Genomics, 40: 371–374.
Taguchi, T., Jhanwar, S. C., Siegfried, J. M., Keller, S. M. & Testa, J. R. (1993). Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q and 9p in human malignant mesothelioma. Cancer Res, 53: 4349–4355.
Tanaka, K., Yanoshita, R., Konishi, M., Oshimura, M., Maeda, Y., Mori, T. & Miyaki, M. (1993). Suppression of tumorigenicity in human colon carcinoma cell by introduction of normal chromosome 1p36 region. Oncogene, 8: 2253–2258.
Vargas, M. P., Zhuang, Z., Wang, C., Vortmeyer, A., Linehan, W. M. & Merino, M. J. (1997). Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma. Hum Pathol, 28: 411–415.
Volpi, E. V., Romani, M. & Siniscalco, M. (1994). Subregional mapping of the human lymphocyte-specific protein tyrosine kinase gene (LCK) to 1p35–p34.3 and its position relative to the 1p marker D1S57. Cytogenet Cell Genet 67: 187–189.
Vorobyov, E., Mertsalov, I., Dockhorn-Dwoeniczak, B., Dwoeniczak, B. & Horst, J. (1997). The genomic organization and the full coding region of the human PAX7 gene. Genomics 45: 168–174.
White, P. S., Maris, J. M., Beltinger, C., Sulman, E., Marshall, H. N., Fujimori, M., Kaufman, B. A., Biegel, J. A., Allen, C., Hilliard, C., Valentine, M. B., Look, A. T., Enomoto, H., Sakiyama, S. & Brodeur, G. M. (1995). A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2–36.3. Proc Natl Acad Sci USA 92: 5520–5524.
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muchel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G. & el-Deiry, W. S. (1997). Killer/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141–143.
Yamamoto, K., Kobayashi, H., Miura, O., Hirosawa, S. & Miyasaka, N. (1997). Assignment of IL12RB1 and IL12RB2, interleukin-12 receptor beta1 and beta2 chains, to human chromosome 19 band p13.1 and chromosome 1 band p31.2, respectively, by in situ hybridization. Cytogenet Cell Genet 77: 257–258.
Yeh, S. H., Chen, P. J., Chen, H. L., Lai, M. Y., Wang, C. C. & Chen, D. S. (1994). Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54: 4188–4192.
About this article
Cite this article
Ragnarsson, G., Eiriksdottir, G., Johannsdottir, J. et al. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 79, 1468–1474 (1999). https://doi.org/10.1038/sj.bjc.6690234
- chromosome 1p
- loss of heterozygosity
- survival statistics
- tumour-suppressor gene
Association of DEAR1 Tagging Single Nucleotide Polymorphisms With Breast Cancer in a Sample of Colombian Population: A Case Control Study
Breast Cancer: Basic and Clinical Research (2020)
BioMed Research International (2020)
Frontiers in Cell and Developmental Biology (2020)
Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancer
Significance of TGFBR3 allelic loss in the deregulation of TGFβ signaling in primary human endometrial carcinomas
Oncology Reports (2016)